143 related articles for article (PubMed ID: 36050547)
41. Novel glucagon-like peptide-1 analog delivered orally reduces postprandial glucose excursions in porcine and canine models.
Eldor R; Kidron M; Greenberg-Shushlav Y; Arbit E
J Diabetes Sci Technol; 2010 Nov; 4(6):1516-23. PubMed ID: 21129350
[TBL] [Abstract][Full Text] [Related]
42. Endoproteolysis by isolated membrane peptidases reveal metabolic stability of glucagon-like peptide-1 analogs, exendins-3 and -4.
Thum A; Hupe-Sodmann K; Göke R; Voigt K; Göke B; McGregor GP
Exp Clin Endocrinol Diabetes; 2002 May; 110(3):113-8. PubMed ID: 12012270
[TBL] [Abstract][Full Text] [Related]
43. Minireview: the glucagon-like peptides.
Drucker DJ
Endocrinology; 2001 Feb; 142(2):521-7. PubMed ID: 11159819
[TBL] [Abstract][Full Text] [Related]
44. Experiences and Translatability of
Emeh P; Breitholtz K; Berg S; Vedin C; Englund M; Uggla T; Antonsson M; Nunes F; Hilgendorf C; Bergström CAS; Davies N
Mol Pharm; 2024 Jan; 21(1):313-324. PubMed ID: 38054599
[TBL] [Abstract][Full Text] [Related]
45. Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study.
Madsen KB; Askov-Hansen C; Naimi RM; Brandt CF; Hartmann B; Holst JJ; Mortensen PB; Jeppesen PB
Regul Pept; 2013 Jun; 184():30-9. PubMed ID: 23511332
[TBL] [Abstract][Full Text] [Related]
46. Dexamethasone plus glucagon-like peptide 2 given to lactating rat dams has a late effect on intestinal lipid uptake in the weanling offspring.
Iordache C; Drozdowski L; Clandinin T; Wild G; Todd Z; Thomson AB
JPEN J Parenter Enteral Nutr; 2004; 28(5):355-63. PubMed ID: 15449577
[TBL] [Abstract][Full Text] [Related]
47. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor.
Yusta B; Somwar R; Wang F; Munroe D; Grinstein S; Klip A; Drucker DJ
J Biol Chem; 1999 Oct; 274(43):30459-67. PubMed ID: 10521425
[TBL] [Abstract][Full Text] [Related]
48. Identifying glucagon-like peptide-1 mimetics using a novel functional reporter gene high-throughput screening assay.
Chen J; Bai G; Yang Y; Geng P; Cao Y; Zhu Y
Peptides; 2007 Apr; 28(4):928-34. PubMed ID: 17267075
[TBL] [Abstract][Full Text] [Related]
49. Impact of Intestinal Concentration and Colloidal Structure on the Permeation-Enhancing Efficiency of Sodium Caprate in the Rat.
Berg S; Kärrberg L; Suljovic D; Seeliger F; Söderberg M; Perez-Alcazar M; Van Zuydam N; Abrahamsson B; Hugerth AM; Davies N; Bergström CAS
Mol Pharm; 2022 Jan; 19(1):200-212. PubMed ID: 34928160
[TBL] [Abstract][Full Text] [Related]
50. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.
Lau J; Bloch P; Schäffer L; Pettersson I; Spetzler J; Kofoed J; Madsen K; Knudsen LB; McGuire J; Steensgaard DB; Strauss HM; Gram DX; Knudsen SM; Nielsen FS; Thygesen P; Reedtz-Runge S; Kruse T
J Med Chem; 2015 Sep; 58(18):7370-80. PubMed ID: 26308095
[TBL] [Abstract][Full Text] [Related]
51. Degradation and Stabilization of Peptide Hormones in Human Blood Specimens.
Yi J; Warunek D; Craft D
PLoS One; 2015; 10(7):e0134427. PubMed ID: 26222180
[TBL] [Abstract][Full Text] [Related]
52. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.
Jin CH; Chae SY; Son S; Kim TH; Um KA; Youn YS; Lee S; Lee KC
J Control Release; 2009 Feb; 133(3):172-7. PubMed ID: 18977255
[TBL] [Abstract][Full Text] [Related]
53. Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity.
Deacon CF; Knudsen LB; Madsen K; Wiberg FC; Jacobsen O; Holst JJ
Diabetologia; 1998 Mar; 41(3):271-8. PubMed ID: 9541166
[TBL] [Abstract][Full Text] [Related]
54. Allosteric modulation of the activity of the glucagon-like peptide-1 (GLP-1) metabolite GLP-1 9-36 amide at the GLP-1 receptor.
Li N; Lu J; Willars GB
PLoS One; 2012; 7(10):e47936. PubMed ID: 23094100
[TBL] [Abstract][Full Text] [Related]
55. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.
Mojsov S; Weir GC; Habener JF
J Clin Invest; 1987 Feb; 79(2):616-9. PubMed ID: 3543057
[TBL] [Abstract][Full Text] [Related]
56. Proglucagon-derived peptides in intestinal epithelial proliferation: glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats.
Ghatei MA; Goodlad RA; Taheri S; Mandir N; Brynes AE; Jordinson M; Bloom SR
Dig Dis Sci; 2001 Jun; 46(6):1255-63. PubMed ID: 11414302
[TBL] [Abstract][Full Text] [Related]
57. The role of citric acid in oral peptide and protein formulations: relationship between calcium chelation and proteolysis inhibition.
Welling SH; Hubálek F; Jacobsen J; Brayden DJ; Rahbek UL; Buckley ST
Eur J Pharm Biopharm; 2014 Apr; 86(3):544-51. PubMed ID: 24384069
[TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetics and metabolism studies on the glucagon-like peptide-1 (GLP-1)-derived metabolite GLP-1(9-36)amide in male Beagle dogs.
Eng H; Sharma R; McDonald TS; Landis MS; Stevens BD; Kalgutkar AS
Xenobiotica; 2014 Sep; 44(9):842-8. PubMed ID: 24588343
[TBL] [Abstract][Full Text] [Related]
59. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C
Twarog C; Liu K; O'Brien PJ; Dawson KA; Fattal E; Illel B; Brayden DJ
Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
[TBL] [Abstract][Full Text] [Related]
60. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
Navarro M; Rodriquez de Fonseca F; Alvarez E; Chowen JA; Zueco JA; Gomez R; Eng J; Blázquez E
J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
